Type of prostate cancer-Adenocarcinoma Posts on Medivizor
Navigation Menu

Type of prostate cancer-Adenocarcinoma Posts on Medivizor

Evaluating the overall survival in patients with non-metastatic castration-resistant prostate cancer treated with apalutamide

Posted by on Oct 27, 2019 in Prostate cancer | 0 comments

In a nutshell This study investigated the effect of apalutamide (Erleada) on survival in patients with castrate-resistant prostate cancer (CRPC). This study found that apalutamide had a positive effect on the survival of these patients. Some background One treatment option for patients with prostate cancer is androgen deprivation therapy...

Read More

Looking for patients with advanced prostate cancer to test a new treatment strategy

Posted by on Oct 24, 2019 in Prostate cancer | 0 comments

In a nutshell This phase 2 study will investigate cryosurgical freezing (CF) and intratumoral combination immunotherapy (ITI) in advanced prostate cancer (PC). The main outcome will be the reduction in prostate specific antigen (PSA). This trial is recruiting in California and Michigan, US. The details Metastatic prostate cancer (PC) is an...

Read More

Searching for patients with prostate cancer to test an experimental treatment before surgery

Posted by on Oct 3, 2019 in Prostate cancer | 0 comments

In a nutshell This trial is investigating the effectiveness of pembrolizumab (Keytruda) plus enzalutamide (Xtandi) in patients with prostate cancer. The primary outcome to be measured will be the absence of cancer on the prostate after it is surgically removed. This study is being conducted in Portland, OR. The details...

Read More

Looking for patients with high-risk prostate cancer to test a combination therapy

Posted by on Aug 31, 2019 in Prostate cancer | 0 comments

In a nutshell This study aims to examine the effectiveness of niraparib (Zejula) combined with hormone therapy and radiotherapy to treat patients with high-risk prostate cancer. The main outcome to be measured will be how long patients remain cancer-free. This study is recruiting in Philadelphia, PA. The details Prostate cancer occurs mostly...

Read More

Looking for patients with advanced prostate cancer to test a new drug

Posted by on Jul 21, 2019 in Prostate cancer | 0 comments

In a nutshell This phase 1 trial will investigate the safety of an experimental drug, XmAb22841 (XmAb), to treat advanced cancer. The main outcome will be the safety and tolerability of XmAb. This study is recruiting in Georgia and Texas, USA. The details Advanced cancer can be difficult to treat. New drugs are being developed to address this. Immune...

Read More

Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer

Posted by on Jul 21, 2019 in Prostate cancer | 0 comments

In a nutshell This study aimed to evaluate ultra-hypofractionated radiation therapy (UHFRT). This study found that UHFRT is safe and effective in the treatment of prostate cancer.  Some background One option for the treatment of prostate cancer is radiation therapy. Conventional radiation treatment (CRT) involves using small doses of radiation 5...

Read More

Outcomes and side-effects after prostate surgery and intensity modulated radiation therapy

Posted by on Jul 21, 2019 in Prostate cancer | 0 comments

In a nutshell This study aimed to investigate long-term outcomes of radiation therapy after prostate surgery for prostate cancer. This study found that this is a safe treatment option for these patients. Some background Prostate surgery is a common treatment for prostate cancer (PCa). Intensity-modulated radiation therapy (IMRT) is another option....

Read More

Searching for patients with castration-resistant prostate cancer to test this new treatment option

Posted by on May 28, 2019 in Prostate cancer | 0 comments

In a nutshell This phase 2 trial is examining the effectiveness and safety of sacituzumab govitecan (IMMU-132) in patients with metastatic castration-resistant prostate cancer (mCRPC) who are having cancer progression on abiraterone (Zytiga) or enzalutamide (Xtandi). The main outcome to be measured will be the PSA (a...

Read More

Looking for patients with localized prostate cancer to test stereotactic body radiotherapy after surgery

Posted by on May 19, 2019 in Prostate cancer | 0 comments

In a nutshell This phase 2 trial will investigate the safety and effectiveness of stereotactic body radiation therapy (SBRT)  in patients with localized prostate cancer (PC) who had surgical removal of the prostate. The main outcomes will be survival without recurrence and side effects. This study is recruiting in Los Angeles, California, the...

Read More